Mitochondrial genomic analysis of late onset Alzheimer's disease reveals protective haplogroups H6A1A/H6A1B: the Cache County Study on Memory in Aging

• Published in: PloS one Vol. 7; no. 9; p. e45134
• Main Authors: Ridge, Perry G, Maxwell, Taylor J, Corcoran, Christopher D, Norton, Maria C, Tschanz, Joann T, O'Brien, Elizabeth, Kerber, Richard A, Cawthon, Richard M, Munger, Ronald G, Kauwe, John S K
• Format: Journal Article
• Language: English
• Published: United States Public Library of Science 17.09.2012; Public Library of Science (PLoS)
• Subjects: Aged; Aging; Aging - genetics; Alzheimer Disease - genetics; Alzheimer Disease - physiopathology; Alzheimer's disease; Bioinformatics; Biology; Brain; Computer memory; Cytochrome; Dehydrogenases; Dementia disorders; Demography; Deoxyribonucleic acid; DNA; DNA, Mitochondrial - genetics; Epidemiology; Extrachromosomal inheritance; Families & family life; Family medical history; Female; Genetic aspects; Genetic Predisposition to Disease; Genetic Variation; Genetics; Genome, Mitochondrial - genetics; Genomes; Genomic analysis; Genomics; Haplotypes; Haplotypes - genetics; Humans; Male; Medicine; Memory; Metabolism; Mitochondrial DNA; Mitochondrial inheritance; Morphology; Mutation; Neurodegenerative diseases; Nucleotide sequence; Phosphorylation; Physiological aspects; Population studies; Risk; Risk Factors; Studies; Utah; Utah; United States; United States > US; Kentucky
• ISSN: 1932-6203; 1932-6203
• DOI: 10.1371/journal.pone.0045134

Alzheimer's disease (AD) is the most common cause of dementia and AD risk clusters within families. Part of the familial aggregation of AD is accounted for by excess maternal vs. paternal inheritance, a pattern consistent with mitochondrial inheritance. The role of specific mitochondrial DNA (mtDNA) variants and haplogroups in AD risk is uncertain. We determined the complete mitochondrial genome sequence of 1007 participants in the Cache County Study on Memory in Aging, a population-based prospective cohort study of dementia in northern Utah. AD diagnoses were made with a multi-stage protocol that included clinical examination and review by a panel of clinical experts. We used TreeScanning, a statistically robust approach based on haplotype networks, to analyze the mtDNA sequence data. Participants with major mitochondrial haplotypes H6A1A and H6A1B showed a reduced risk of AD (p=0.017, corrected for multiple comparisons). The protective haplotypes were defined by three variants: m.3915G>A, m.4727A>G, and m.9380G>A. These three variants characterize two different major haplogroups. Together m.4727A>G and m.9380G>A define H6A1, and it has been suggested m.3915G>A defines H6A. Additional variants differentiate H6A1A and H6A1B; however, none of these variants had a significant relationship with AD case-control status. Our findings provide evidence of a reduced risk of AD for individuals with mtDNA haplotypes H6A1A and H6A1B. These findings are the results of the largest study to date with complete mtDNA genome sequence data, yet the functional significance of the associated haplotypes remains unknown and replication in others studies is necessary.